Biblio

Export 1092 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Keyword is C  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
F. Piazza, Greenberg, S. M., Savoiardo, M., Gardinetti, M., Chiapparini, L., Raicher, I., Nitrini, R., Sakaguchi, H., Brioschi, M., Billo, G., Colombo, A., Lanzani, F., Piscosquito, G., Carriero, M. Rita, Giaccone, G., Tagliavini, F., Ferrarese, C., and DiFrancesco, J. C., Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies., Ann Neurol, vol. 73, no. 4, pp. 449-58, 2013.
F. Piazza, Greenberg, S. M., Savoiardo, M., Gardinetti, M., Chiapparini, L., Raicher, I., Nitrini, R., Sakaguchi, H., Brioschi, M., Billo, G., Colombo, A., Lanzani, F., Piscosquito, G., Carriero, M. Rita, Giaccone, G., Tagliavini, F., Ferrarese, C., and DiFrancesco, J. C., Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies., Ann Neurol, vol. 73, no. 4, pp. 449-58, 2013.
J. Bastrup, Hansen, K. H., Poulsen, T. B. G., Kastaniegaard, K., Asuni, A. A., Christensen, S., Belling, D., Helboe, L., Stensballe, A., and Volbracht, C., Anti-Aβ Antibody Aducanumab Regulates the Proteome of Senile Plaques and Closely Surrounding Tissue in a Transgenic Mouse Model of Alzheimer's Disease., J Alzheimers Dis, vol. 79, no. 1, pp. 249-265, 2021.
J. Bastrup, Hansen, K. H., Poulsen, T. B. G., Kastaniegaard, K., Asuni, A. A., Christensen, S., Belling, D., Helboe, L., Stensballe, A., and Volbracht, C., Anti-Aβ Antibody Aducanumab Regulates the Proteome of Senile Plaques and Closely Surrounding Tissue in a Transgenic Mouse Model of Alzheimer's Disease., J Alzheimers Dis, vol. 79, no. 1, pp. 249-265, 2021.
T. E. Golde, Schneider, L. S., and Koo, E. H., Anti-aβ therapeutics in Alzheimer's disease: the need for a paradigm shift., Neuron, vol. 69, no. 2, pp. 203-13, 2011.
I. Liampas, Hatzimanolis, A., Siokas, V., Yannakoulia, M., Kosmidis, M. H., Sakka, P., Hadjigeorgiou, G. M., Scarmeas, N., and Dardiotis, E., Antihypertensive Medication Class and the Risk of Dementia and Cognitive Decline in Older Adults: A Secondary Analysis of the Prospective HELIAD Cohort., J Alzheimers Dis, vol. 89, no. 2, pp. 709-719, 2022.
I. Liampas, Hatzimanolis, A., Siokas, V., Yannakoulia, M., Kosmidis, M. H., Sakka, P., Hadjigeorgiou, G. M., Scarmeas, N., and Dardiotis, E., Antihypertensive Medication Class and the Risk of Dementia and Cognitive Decline in Older Adults: A Secondary Analysis of the Prospective HELIAD Cohort., J Alzheimers Dis, vol. 89, no. 2, pp. 709-719, 2022.
T. June Yoo, Anti-Inflammatory Gene Therapy Improves Spatial Memory Performance in a Mouse Model of Alzheimer's Disease., J Alzheimers Dis, vol. 85, no. 3, pp. 1001-1008, 2022.
S. A. Chau, Chung, J., Herrmann, N., Eizenman, M., and Lanctôt, K. L., Apathy and Attentional Biases in Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 3, pp. 837-46, 2016.
S. A. Chau, Chung, J., Herrmann, N., Eizenman, M., and Lanctôt, K. L., Apathy and Attentional Biases in Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 3, pp. 837-46, 2016.
J. R. Burrell, Ballard, K. J., Halliday, G. M., and Hodges, J. R., Aphasia in Progressive Supranuclear Palsy: As Severe as Progressive Non-Fluent Aphasia., J Alzheimers Dis, vol. 61, no. 2, pp. 705-715, 2018.
J. R. Burrell, Ballard, K. J., Halliday, G. M., and Hodges, J. R., Aphasia in Progressive Supranuclear Palsy: As Severe as Progressive Non-Fluent Aphasia., J Alzheimers Dis, vol. 61, no. 2, pp. 705-715, 2018.
M. Berger, Cooter, M., Roesler, A. S., Chung, S., Park, J., Modliszewski, J. L., VanDusen, K. W., J Thompson, W., Moseley, A., Devinney, M. J., Smani, S., Hall, A., Cai, V., Browndyke, J. N., Lutz, M. W., and Corcoran, D. L., APOE4 Copy Number-Dependent Proteomic Changes in the Cerebrospinal Fluid., J Alzheimers Dis, vol. 79, no. 2, pp. 511-530, 2021.
S. K. Singhrao, Harding, A., Chukkapalli, S., Olsen, I., Kesavalu, L., and Crean, S. J., Apolipoprotein E Related Co-Morbidities and Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 4, pp. 935-48, 2016.
S. K. Singhrao, Harding, A., Chukkapalli, S., Olsen, I., Kesavalu, L., and Crean, S. J., Apolipoprotein E Related Co-Morbidities and Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 4, pp. 935-48, 2016.
Y. Ling Chai, Yeo, H. Kai- Hui, Wang, J., Hilal, S., Ikram, M. Kamran, Venketasubramanian, N., Wong, B. - S., and Chen, C. Li- Hsian, Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort., J Alzheimers Dis, vol. 51, no. 4, pp. 1111-8, 2016.
Y. Ling Chai, Yeo, H. Kai- Hui, Wang, J., Hilal, S., Ikram, M. Kamran, Venketasubramanian, N., Wong, B. - S., and Chen, C. Li- Hsian, Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort., J Alzheimers Dis, vol. 51, no. 4, pp. 1111-8, 2016.
R. Pluta, Bogucka-Kocka, A., Bogucki, J., Kocki, J., and Czuczwar, S. J., Apoptosis, Autophagy, and Mitophagy Genes in the CA3 Area in an Ischemic Model of Alzheimer's Disease with 2-Year Survival., J Alzheimers Dis, vol. 99, no. 4, pp. 1375-1383, 2024.
R. Pluta, Bogucka-Kocka, A., Bogucki, J., Kocki, J., and Czuczwar, S. J., Apoptosis, Autophagy, and Mitophagy Genes in the CA3 Area in an Ischemic Model of Alzheimer's Disease with 2-Year Survival., J Alzheimers Dis, vol. 99, no. 4, pp. 1375-1383, 2024.
T. B. Shea and Remington, R., Apparent Cognitive Decline as Revealed by an Executive Function Test within a Cohort of Elderly Individuals Self-Reporting Normal Cognitive Performance., J Alzheimers Dis, vol. 61, no. 3, pp. 913-915, 2018.
T. B. Shea and Remington, R., Apparent Cognitive Decline as Revealed by an Executive Function Test within a Cohort of Elderly Individuals Self-Reporting Normal Cognitive Performance., J Alzheimers Dis, vol. 61, no. 3, pp. 913-915, 2018.
T. B. Shea and Remington, R., Apparent Cognitive Decline as Revealed by an Executive Function Test within a Cohort of Elderly Individuals Self-Reporting Normal Cognitive Performance., J Alzheimers Dis, vol. 61, no. 3, pp. 913-915, 2018.
H. - F. Wang, Tan, L., Cao, L., Zhu, X. - C., Jiang, T., Tan, M. - S., Liu, Y., Wang, C., Tsai, R. M., Jia, J. - P., and Yu, J. - T., Application of the IWG-2 Diagnostic Criteria for Alzheimer's Disease to the ADNI., J Alzheimers Dis, vol. 51, no. 1, pp. 227-36, 2016.
J. A. Snir, Suchy, M., Bindseil, G. A., Kovacs, M., Chronik, B. A., Hudson, R. H. E., Pasternak, S. H., and Bartha, R., An Aspartyl Cathepsin Targeted PET Agent: Application in an Alzheimer's Disease Mouse Model., J Alzheimers Dis, vol. 61, no. 3, pp. 1241-1252, 2018.
J. A. Snir, Suchy, M., Bindseil, G. A., Kovacs, M., Chronik, B. A., Hudson, R. H. E., Pasternak, S. H., and Bartha, R., An Aspartyl Cathepsin Targeted PET Agent: Application in an Alzheimer's Disease Mouse Model., J Alzheimers Dis, vol. 61, no. 3, pp. 1241-1252, 2018.

Pages